Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
Clinical trial NCT04893148 · UNKNOWN
Trial details
- NCT number
- NCT04893148
- Sponsor
- Chungbuk National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2021-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.